Diabetes Surgery: Current Indications and Techniques

1.

World Health Organization, Global Health Observatory (GHO) data (2008) Obesity, situation and trends. http://www.who.int/gho/ncd/risk_factors/overweight/en

2.

McPherson K, Marsh T, Brown M (2007) Tackling obesities: The future choices: modelling future trends in obesity and their impact on health. UK Government Foresight Programme, Government Office for Science, London. https://www.researchgate.net/publication/242459208_Tackling_Obesities_The_Future_Choices-Modelling_Future_Trends_in_Obesity_Their_Impact_on_Health

3.

Atallah R, Filion KB, Wakil SM et al (2014) Long-term effects of 4 popular diets on weight loss and cardiovascular risk factors: a systematic review of randomized controlled trials. Circ Cardiovasc Qual Outcomes 7:815–827 CrossRefPubMed

4.

Leblanc ES, O’Connor E, Whitlock EP et al (2011) Effectiveness of primary care-relevant treatments for obesity in adults: a systematic evidence review for the US Preventive Services Task Force. Ann Intern Med 155:434–447 CrossRefPubMed

5.

Buchwald H, Avidor Y, Braunwald E et al (2004) Bariatric surgery: a systematic review and meta-analysis. JAMA 292:1724–1737 CrossRefPubMed

6.

Sjostrom L (2013) Review of the key results from the Swedish Obese Subjects (SOS) trial: a prospective controlled intervention study of bariatric surgery. J Intern Med 273:219–234 CrossRefPubMed

7.

Rubino F, Gagner M (2002) Potential of surgery for curing type 2 diabetes mellitus. Ann Surg 236:554–559 CrossRefPubMedPubMedCentral

8.

Dixon JB, Zimmet P, Alberti KG et al (2011) Bariatric surgery for diabetes: the International Diabetes Federation takes a position. J Diabetes 3:261–264 CrossRefPubMed

9.

Patel SR, Hakim D, Mason J, Hakim N (2013) The duodenal-jejunal bypass sleeve (Endo-Barrier Gastrointestinal Liner) for weight loss and treatment of type 2 diabetes. Surg Obes Relat Dis 9:482–484 CrossRefPubMed

10.

Cummings BP, Strader AD, Stanhope KL et al (2010) Ileal interposition surgery improves glucose and lipid metabolism and delays diabetes onset in the UCD-T2DM rat. Gastroenterology 138:2437–2446 CrossRefPubMedPubMedCentral

11.

Tinoco A, El-Kadre L, Aquiar L et al (2011) Short-term and mid-term control of type 2 diabetes mellitus by laparoscopic sleeve gastrectomy with ileal interposition. World J Surg 35:2238–2244 CrossRefPubMed

12.

Sandler BJ, Rumbaut R, Swain CP et al (2015) One-year human experience with a novel endoluminal, endoscopic gastric bypass sleeve for morbid obesity. Surg Endosc 29:3298–3303 CrossRefPubMed

13.

Shuang J, Zhang Y, Ma L et al (2015) Relief of diabetes by duodenal-jejunal bypass sleeve implantation in the high-fat diet and streptozotocin-induced diabetic rat model is associated with an increase in GLP-1 levels and the number of GLP-1-positive cells. Exp Ther Med 10:1355–1363 PubMedPubMedCentral

14.

Schumann R (2011) Anaesthesia for bariatric surgery. Best Pract Res Clin Anaesthesiol 25:83–93 CrossRefPubMed

15.

Greenstein AJ, Wahed AS, Adeniji A et al (2012) Prevalence of adverse intraoperative events during obesity surgery and their sequelae. J Am Coll Surg 215:271–277e3 CrossRefPubMedPubMedCentral

16.

Rubino F, Gagner M (2002) Potential of surgery for curing type 2 diabetes mellitus. Ann Surg 236:554–559 CrossRefPubMedPubMedCentral

17.

Moo TA, Rubino F (2008) Gastrointestinal surgery as treatment for type 2 diabetes. Curr Opin Endocrinol Diabetes Obes 15:153–158 CrossRefPubMed

18.

Meek CL, Lewis HB, Reimann F et al (2016) The effect of bariatric surgery on gastrointestinal and pancreatic peptide hormones. Peptides 77:28–37 CrossRefPubMed

19.

Patel RT, Shukla AP, Ahn SM et al (2014) Surgical control of obesity and diabetes: the role of intestinal vs. gastric mechanisms in the regulation of body weight and glucose homeostasis. Obesity (Silver Spring) 22:159–169 CrossRef

20.

Rubino F, R’bibo SL, del Genio F et al (2010) Metabolic surgery: the role of the gastrointestinal tract in diabetes mellitus. Nat Rev Endocrinol 6:102–109 CrossRefPubMedPubMedCentral

21.

Pournaras DJ, Glicksman C, Vincent RP et al (2012) The role of bile after Roux-en-Y gastric bypass in promoting weight loss and improving glycaemic control. Endocrinology 153:3613–3619 CrossRefPubMedPubMedCentral

22.

Pepino MY, Bradley D, Eagon JC et al (2014) Changes in taste perception and eating behavior after bariatric surgery-induced weight loss in women. Obesity (Silver Spring) 22:E13–20 CrossRefPubMed

23.

Gautron L, Zechner JF, Aguirre V (2013) Vagal innervation patterns following Roux-en-Y gastric bypass in the mouse. Int J Obes (Lond) 37:1603–1607 CrossRef

24.

Sjöström L, Lindroos AK, Peltonen M et al (2004) Swedish Obese Subjects Study Scientific Group. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med 351:2683–2693 PubMed

25.

Gill RS, Birch DW, Shi X et al (2010) Sleeve gastrectomy and type 2 diabetes mellitus: a systematic review. Surg Obes Relat Dis 6:707–713 CrossRefPubMed

26.

Schauer PR, Bhatt DL, Kirwan JP et al (2014) Bariatric surgery versus intensive medical therapy for diabetes: 3-year outcomes. N Engl J Med 370:2002–2013 CrossRefPubMed

27.

Ikramuddin S, Korner J, Lee WJ et al (2013) Roux-en-Y gastric bypass vs intensive medical management for the control of type 2 diabetes, hypertension, and hyperlipidemia: the Diabetes Surgery Study randomized clinical trial. JAMA 309:2240–2249 CrossRefPubMedPubMedCentral

28.

Mingrone G, Panunzi S, De Gaetano A et al (2012) Bariatric surgery versus conventional medical therapy for type 2 diabetes. N Engl J Med 366:1577–1585 CrossRefPubMed

29.

Sjöström L, Peltonen M, Jacobson P et al (2014) Association of bariatric surgery with long-term remission of type 2 diabetes and with microvascular and macrovascular complications. JAMA 311:2297–2304 CrossRefPubMed

30.

Mingrone G, Panunzi S, De Gaetano A (2015) Bariatric-metabolic surgery versus conventional medical treatment in obese patients with type 2 diabetes: 5-year follow-up of an open-label, single-centre, randomised controlled trial. Lancet 386:964–973 CrossRefPubMed

31.

Cohen RV, Pinheiro JC, Schiavon CA et al (2012) Effects of gastric bypass surgery in patients with type 2 diabetes and only mild obesity. Diabetes Care 35:1420–1428 CrossRefPubMedPubMedCentral

32.

Dixon JB, O’Brien PE, Playfair J et al (2008) Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial. JAMA 299:316–323 PubMed

33.

Rubino F, Shukla A, Pomp A et al (2014) Bariatric, metabolic, and diabetes surgery: what’s in a name? Ann Surg 259:117–122 CrossRefPubMed

Medicine Matters Diabetes

18. Diabetes Surgery: Current Indications and Techniques

Abstract